Decitabine for treatment of myelodysplastic syndrome in an elderly patient and review of literature / 南方医科大学学报
Journal of Southern Medical University
;
(12): 280-282, 2012.
Artigo
em Chinês
| WPRIM
| ID: wpr-267616
ABSTRACT
Findings in epigenetic changes in meylodysplastic syndromes (MDS) and the development of demethylating drugs provide a new approach to the treatment of MDS. We used standard-dose decitabine for treatment of MDS in an elderly patient with an International Prostate Symptom Score (IPSS) of moderate risk group 2, and achieved a complete response in the first course. We report our experience with this case and review the relevant literatures.
Texto completo:
DisponíveL
Índice:
WPRIM (Pacífico Ocidental)
Assunto principal:
Azacitidina
/
Síndromes Mielodisplásicas
/
Metilases de Modificação do DNA
/
Usos Terapêuticos
/
Tratamento Farmacológico
Limite:
Feminino
/
Humanos
Idioma:
Chinês
Revista:
Journal of Southern Medical University
Ano de publicação:
2012
Tipo de documento:
Artigo
Similares
MEDLINE
...
LILACS
LIS